Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-16.50%
Monthly Change
-9.47%
6 month change
-16.50%
Year Change
-20.74%
Previous Close
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Volume
15
Markets
US Stock Market
Healthcare
SEER
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
Total assets
539.14 M
487.93 M
436.27 M
366.6 M
Total liabilities
36.22 M
40.94 M
39.37 M
39.03 M
Total equity
502.92 M
446.99 M
396.9 M
327.57 M
Total liabilities & shareholders' equities
539.14 M
487.93 M
436.27 M
366.6 M
Total debt
—
—
—
—
Net debt
—
—
—
—
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
News
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer earnings beat by $0.02, revenue fell short of estimates
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way
Seer earnings missed by $0.01, revenue topped estimates
Seer Q3 2025 slides: modest revenue growth amid strategic repositioning
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Seer to showcase proteomics platform at ASHG 2025 annual meeting